Send us Feedback

Trinity Biotech (TRIB)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

TRIB » Topics » Trinity Biotech plc Unaudited Condensed Consolidated Statement of Cash Flows

This excerpt taken from the TRIB 6-K filed Jan 7, 2005.

Trinity Biotech plc
Unaudited Condensed Consolidated Statement of Cash Flows

      Nine months ended September 30   
     
2004
2003
 
     
US$
US$
  
     
(Unaudited)
(Unaudited)
  
               
Net cash flow from operating activities   (2,988,144 )   2,460,622  
               
Investing activities            
  Interest received   219,953     93,560  
  Payment for tangible fixed assets   (2,664,598 )   (1,456,544 )
  Payment for licenses and deferred development costs   (2,479,452 )   (1,219,930 )
  Payments to acquire trades or businesses   (19,156,104 )   (474,913 )
  Deferred acquisition consideration paid   —     (3,574,053 )
               
      (24,080,201 )   (6,631,880 )
Financing activities            
  Interest paid   (624,423 )   (377,437 )
  Issue of ordinary share capital including premium and issuance costs   23,957,310     318,983  
  (Decrease)/Increase in long term debt   (2,491,601 )   1,285,734  
  Repayment of other financial liabilities   (2,249,055 )   (2,150,985 )
  Issue of convertible debentures   5,000,000     20,000,000  
  Repayment of minority interest   —     (309,946 )
      23,592,231     18,766,349  
               
  Decrease in cash and cash equivalents   (3,476,114 )   14,595,091  
  Non cash exchange movement   (8,278 )   312,589  
  Balance at beginning of period   20,563,418     5,807,514  
  Balance at end of period   17,079,026     20,715,194  

8

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki